◂ Announcements

Jul 25, 2019NEW FACILITYDurham and Wilson, North Carolina, United States

Merck to build $650M vaccine plant in Durham, North Carolina

Merck will invest over $650 million to build a new 225,000-square-foot manufacturing facility in Durham, North Carolina, and expand packaging operations in Wilson, creating 425 jobs total, to meet demand for Gardasil HPV vaccine.

Value

$680.0M

Jobs

425

Status

Announced

ProductsGardasil HPV vaccine

CompaniesMerck

Sectors#Medical Devices

“Merck is delighted to bring additional investment and jobs to North Carolina.”edpnc.com

1 source
edpnc.comMerck to Build $650M Plant in NC to Meet Gardasil Vaccine Demand - EDPNCwebmaster@push10.comJul 25, 2019

Summarized from public sources; check the original articles before acting on it.

More from Merck

profile ▸

May 31, 2022NEW FACILITYZhangjiagang, Jiangsu province, China$82.1M
Merck to build Advanced Semiconductor Integration Site in Zhangjiagang, China
Merck investinchina.chinadaily.com.cn
May 23, 2022EXPANSIONCork, Ireland, Ireland$464.0M370 jobsops 2027
Merck invests EUR 440M to expand filtration and membrane production in Cork, Ireland
Merck merckgroup.com
Apr 28, 2022EXPANSIONWuxi National High-Tech District, China$110.0M1,000 jobsops 2024
Merck expands life science manufacturing in Wuxi, China with $110M investment
Merck govt.chinadaily.com.cn
Sep 30, 2021ACQUISITIONUnited States$11.5B
Merck to acquire Acceleron Pharma for $11.5 billion
Merck acquirer Acceleron Pharma Inc. target merck.com
Sep 21, 2021EXPANSIONGernsheim, Hesse, Germany$32.8Mops 21 Sep 2021
Merck starts second production line for silica-based effect pigments in Gernsheim
Merck merckgroup.com
May 26, 2021CONTRACTGermany
Bodo Möller Chemie takes over distribution of Merck Surface Solutions in Europe
Bodo Möller Chemie Group Merck customer bm-chemie.com

Loading…

Merck to build $650M vaccine plant in Durham, North Carolina · Endata